AGEN Stock Analysis

AGEN -  USA Stock  

USD 5.26  0.06  1.13%

The latest price rise of Agenus Inc could raise concerns from institutional investors as the firm it trading at a share price of 5.26 on 6,908,600 in volume. The company management teams may have good odds in positioning the firm resources to exploit market volatility in July. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.72. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Agenus partners.
Please continue to Trending Equities.

Search Stock Analysis 

 
Refresh
The Agenus stock analysis report makes it easy to digest most publicly released information about Agenus and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. AGEN stock analysis module also helps to analyze the Agenus price relationship with some important fundamental indicators such as market cap and management efficiency.

AGEN Stock Analysis Notes

About 13.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.02. Agenus Inc next dividend is scheduled to be issued on the 29th of October 2010. The entity had 1:6 split on the 3rd of October 2011. Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts. Agenus operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 359 people. For more info on Agenus Inc please contact Garo Armen at 781 674-4400 or go to www.agenusbio.com.

Agenus Quarterly Cost of Revenue

1.1 MillionShare

Agenus Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Agenus' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Agenus Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Agenus Inc appears to be risky and price may revert if volatility continues
Agenus Inc has high likelihood to experience some financial distress in the next 2 years
The company currently holds 57.62 M in liabilities with Debt to Equity (D/E) ratio of 0.61, which is about average as compared to similar companies. Agenus Inc has a current ratio of 0.96, indicating that it has a negative working capital and may not be able to pay financial obligations when due.
The entity reported the previous year's revenue of 84.76 M. Net Loss for the year was (190.13 M) with loss before overhead, payroll, taxes, and interest of (56.8 M).
Agenus Inc currently holds about 119.37 M in cash with (147.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.54.
Agenus Inc has a frail financial position based on the latest SEC disclosures
Roughly 13.0% of Agenus shares are held by company insiders
Latest headline from www.marketwatch.com: Agenus Gets FDA Priority Review of Balstilimab in Cervical Cancer AGEN - MarketWatch

Agenus Inc Upcoming and Recent Events

Earnings reports are used by Agenus to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Agenus previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report5th of August 2021
Next Earnings Report4th of November 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End21st of March 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

AGEN Largest EPS Surprises

Earnings surprises can significantly impact Agenus' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2014-10-31
2014-09-30-0.15-0.130.0213 
2020-05-07
2020-03-31-0.345-0.310.03510 
2021-05-06
2021-03-31-0.3067-0.270.036711 
View All Earnings Estimates

Agenus SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Agenus prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Agenus investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Agenus Inc specific information freely available to individual and institutional investors to make a timely investment decision.
18th of May 2021
Financial Statements and Exhibits. Entry into a Material Definitive Agreement
View
6th of May 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
6th of April 2021
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
15th of March 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
16th of February 2021
Unclassified Corporate Event
View
12th of February 2021
Unclassified Corporate Event
View
11th of February 2021
Unclassified Corporate Event
View
10th of February 2021
Unclassified Corporate Event
View

Agenus Thematic Classifications

In addition to having Agenus stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Cancer Fighters IdeaCancer Fighters
Public companies from health care and pharmaceutical sectors that are focused on fighting cancer

AGEN Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Agenus is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Agenus Inc backward and forwards among themselves. Agenus' institutional investor refers to the entity that pools money to purchase Agenus' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Blackrock IncCommon Shares14.3 M38.8 M
Rtw Investments LpCommon Shares13.8 M37.5 M
State Street CorpCommon Shares12.7 M34.5 M
Vanguard Group IncCommon Shares11.8 M32.1 M
Oracle Investment Management IncCommon Shares9.4 M25.5 M
Cormorant Asset Management LpCommon Shares7.8 M21.1 M
Artal Group SaCommon SharesM16.3 M
Susquehanna International Group LlpCall Options950.6 K2.6 M
Note, although Agenus' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

AGEN Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 1.12 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Agenus's market, we take the total number of its shares issued and multiply it by Agenus's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

AGEN Profitablity

Agenus' profitability indicators refer to fundamental financial ratios that showcase Agenus' ability to generate income relative to its revenue or operating costs. If, let's say, Agenus is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Agenus' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Agenus' profitability requires more research than a typical breakdown of Agenus' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (224.06) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (149.34) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -1.49.
Last ReportedProjected for 2021
Return on Investment(104.52) (112.77) 
Return on Average Assets(0.92) (1.00) 
Return on Average Equity 0.89  0.96 
Return on Invested Capital 3.71  4.00 
Return on Sales(1.36) (1.47) 

Management Efficiency

The entity has return on total asset (ROA) of (38.13) % which means that it has lost $38.13 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 0.67 %, meaning that it created $0.67 on every $100 dollars invested by stockholders. Agenus management efficiency ratios could be used to measure how well agenus inc manages its routine affairs as well as how well it operates its assets and liabilities. Agenus Return on Average Equity is quite stable at the moment as compared to the past year. The company's current value of Return on Average Equity is estimated at 0.96. Return on Invested Capital is expected to rise to 4.00 this year, although the value of Return on Investment will most likely fall to (112.77) . Agenus Assets Non Current are quite stable at the moment as compared to the past year. The company's current value of Assets Non Current is estimated at 108.68 Million. Total Assets Per Share is expected to rise to 1.38 this year, although the value of Total Assets will most likely fall to about 177.8 M.
Last ReportedProjected for 2021
Book Value per Share(1.18) (1.21) 
Enterprise Value over EBIT(4.00) (4.32) 
Enterprise Value over EBITDA(4.68) (5.05) 
Price to Book Value(2.97) (3.20) 
Tangible Assets Book Value per Share 1.03  1.06 
Enterprise Value527.3 M434.9 M
Tangible Asset Value178.2 M145.1 M

Technical Drivers

As of the 19th of June, Agenus shows the mean deviation of 3.19, and Risk Adjusted Performance of 0.1267. Agenus Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Agenus Inc, which can be compared to its rivals. Please confirm Agenus Inc jensen alpha, and the relationship between the coefficient of variation and potential upside to decide if Agenus Inc is priced correctly, providing market reflects its regular price of 5.26 per share. Given that Agenus has jensen alpha of 0.8555, we suggest you to validate Agenus Inc's prevailing market performance to make sure the company can sustain itself at a future point.

Agenus Inc Price Movement Analysis

The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Mid-point over period is an average of Agenus Inc highest and lowest values attained during the given period. View also all equity analysis or get more info about midpoint over period overlap studies indicator.

Agenus Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Agenus insiders, such as employees or executives, is commonly permitted as long as it does not rely on Agenus' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Agenus insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Garo Armen over a week ago via Macroaxis 
Agenus exotic insider transaction detected
Garo Armen over three weeks ago via Macroaxis 
Agenus exotic insider transaction detected
Garo Armen over a month ago via Macroaxis 
Agenus exotic insider transaction detected
Hirsch Susan B over two months ago via Macroaxis 
Acquisition by Hirsch Susan B of 5092 shares of Agenus subject to Rule 16b-3
Garo Armen over two months ago via Macroaxis 
Agenus exotic insider transaction detected
Garo Armen over three months ago via Macroaxis 
Agenus exotic insider transaction detected
Garo Armen over three months ago via Macroaxis 
Agenus exotic insider transaction detected
Garo Armen over three months ago via Macroaxis 
Agenus exotic insider transaction detected
Garo Armen over three months ago via Macroaxis 
Agenus exotic insider transaction detected
Oday Steven J over three months ago via Macroaxis 
Agenus exotic insider transaction detected
Garo Armen over three months ago via Macroaxis 
Agenus exotic insider transaction detected
Garo Armen over three months ago via Macroaxis 
Agenus exotic insider transaction detected

Agenus Predictive Daily Indicators

Agenus intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Agenus stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Agenus Forecast Models

Agenus time-series forecasting models is one of many Agenus' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Agenus' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Agenus Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Agenus stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling AGEN shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Agenus. By using and applying AGEN Stock analysis, traders can create a robust methodology for identifying AGEN entry and exit points for their positions.
Last ReportedProjected for 2021
Operating Margin(53.75) (57.99) 
EBITDA Margin(1.28) (1.38) 
Gross Margin 0.97  1.08 
Profit Margin(2.05) (2.22) 
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts. Agenus operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 359 people.

Current AGEN Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. AGEN analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. AGEN analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
7.5Strong Buy2Odds
Agenus Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most AGEN analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand AGEN stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Agenus Inc, talking to its executives and customers, or listening to AGEN conference calls.
AGEN Analyst Advice Details

AGEN Stock Analysis Indicators

Agenus Inc stock analysis indicators help investors evaluate how Agenus stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Agenus shares will generate the highest return on investment. By understating and applying Agenus stock analysis, traders can identify Agenus position entry and exit signals to maximize returns.
Quick Ratio0.88
Fifty Two Week Low2.50
Revenue Growth-22.50%
Shares Short Prior Month27.38M
Average Daily Volume Last 10 Day5.27M
Average Daily Volume In Three Month5.33M
Shares Percent Shares Out12.73%
Gross Margins-72.70%
Short Percent Of Float12.84%
Forward Price Earnings-4.67
Float Shares179.08M
Fifty Two Week High5.95
Enterprise Value To Ebitda-9.18
Fifty Day Average3.78
Two Hundred Day Average3.56
Enterprise Value To Revenue12.93
Please continue to Trending Equities. Note that the Agenus Inc information on this page should be used as a complementary analysis to other Agenus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Agenus Stock analysis

When running Agenus Inc price analysis, check to measure Agenus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agenus is operating at the current time. Most of Agenus' value examination focuses on studying past and present price action to predict the probability of Agenus' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Agenus' price. Additionally, you may evaluate how the addition of Agenus to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
The market value of Agenus Inc is measured differently than its book value, which is the value of AGEN that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus Inc underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine Agenus value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.